Upon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read moreMore on the Guru Syndrome
The key to understanding the guru syndrome is the psychological need of disciples. Although many disciples (at least initially) may have a genuine need for spiritual growth, this is usually combined with a much more unhealthy impulse: a regression to a childlike state of unconditional devotion and irresponsibility.
Read more5-MeO-DMT and Benefit Enhancement Strategies
In a survey, respondents use benefit enhancement strategies that correlate with positive 5-MeO-DMT experiences. This may open the way for further research and emphasis on harm reduction.
Read moreSexual Abuse in Psychedelic Therapy
This article shows how psychedelic therapy also carries a serious risk of sexual abuse. Patients in psychedelic therapy are intensely vulnerable. Please read and beware.
Read moreLSD: Risks and Potential Benefits
This article describes some benefits and risks of taking LSD. Researchers are exploring the role of hallucinogens on treatment-resistant depression, post traumatic stress disorder, cancer-related anxiety, addictions, and even anorexia.
Read moreRisks of Taking Psychedelics
Be sure to read these potential risks before taking psychedelics.
Read more